NCT02489981View on ClinicalTrials.gov

Specific Use-result Surveillance of Spiriva Respimat in Asthmatics

CompletedOBSERVATIONAL
Enrollment

359

Participants

Timeline

Start Date

June 1, 2015

Primary Completion Date

August 1, 2017

Study Completion Date

September 28, 2017

Conditions
Asthma
Interventions
DRUG

Spiriva

60 puffs

Trial Locations (1)

30110-060

Hospital Felício Rocho, Belo Horizonte

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY